Fed. Circ. Won't Touch Hypertension Drug Producer's Loss
By Andrew Karpan · September 14, 2023, 8:13 PM EDT
The Federal Circuit declined Thursday to second-guess a patent ruling out of Delaware federal court that ended a drugmaker's control over the market for liquid versions of its hypertension drug Epaned...
To view the full article, register now.